The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation.
Yi-Hsin ChanKuang-Tso LeeYi-Wei KaoChien-Ying HuangYung-Lung ChenSamuel Chi-Ling HangPao-Hsien ChuPublished in: PloS one (2019)
NOACs showed a comparable risk of efficacy, safety, and composite outcome to well-managed warfarin based on a lower INR target of 1.5-2.5 in Asians with NVAF taking oral anticoagulants.